17 Mar 2015

Cyklokapron Tablets (Tranexamic acid) - United Kingdom

ATC: B02AA
BLOOD AND BLOOD FORMING ORGANS
ANTIHEMORRHAGICS
ANTIFIBRINOLYTICS
AMINO ACIDS
Cyklokapron Tablets

Generic Matches for Tranexamic acid (1)
Cyklokapron Injection

Last Updated on 17 Mar 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Cyklokapron Tablets Indication

Short-term use for haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. Local fibrinolysis as occurs in the following conditions:

- Prostatectomy and bladder surgery

- Menorrhagia

- Epistaxis

- Conisation of the cervix

- Traumatic hyphaema

- Hereditary angioneurotic oedema

- Management of dental extraction in haemophiliacs

 

Cyklokapron Tablets Generic Name

Tranexamic acid

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Cyklokapron 500 mg Film-coated Tablets (external site)

Related Learning Zones

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this free resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately. Content is arranged into sections with disease awareness information, mode of action videos, first-line treatment options, links to useful external hyperammonaemia content and more… 

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Cyklokapron Tablets Marketing Information

Cyklokapron Tablets Generic Name
Tranexamic acid
Marketing Company
Meda Pharmaceuticals Ltd
Drug Type
POM
Date of Issue, Marketing Authority 01/01/1983

Related Drugs - Haematology

Back to top